Engineers Gate Manager’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Engineers Gate Manager’s Portfolio SCMP Stock Details SCMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-261,931	Closed	-$4.7M	–	1081
2017 Q4	$4.7M	Buy	261,931 +205,901	+367%	+$2.54M	0.32%	67
2017 Q3	$661K	Buy	56,030 +3,196	+6%	+$35.9K	0.06%	519
2017 Q2	$555K	Sell	52,834 -24,315	-32%	-$248K	0.05%	490
2017 Q1	$849K	Buy	77,149 +23,501	+44%	+$273K	0.08%	368
2016 Q4	$727K	Buy	+53,648	New	+$748K	0.08%	382
2015 Q4	–	Sell	-23,168	Closed	-$460K	–	887
2015 Q3	$460K	Buy	+23,168	New	+$531K	0.04%	459

Other funds holding SCMP

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Engineers Gate Manager's SCMP Position: Q1 2018 in Review

Engineers Gate Manager sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 261,931 shares — an estimated $4.7M sold.

Engineers Gate Manager first reported a position in SCMP in Q3 2015 and held it in 6 quarters. The position peaked at $4.7M in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

Engineers Gate Manager reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
Engineers Gate Manager sold 261,931 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $4.7M.
Engineers Gate Manager first reported a position in Sucampo Pharmaceuticals, Inc. in Q3 2015 and held it in 6 quarters.
Engineers Gate Manager's Sucampo Pharmaceuticals, Inc. position peaked at $4.7M in Q4 2017.
3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Engineers Gate Manager's 13F filing for Q1 2018, filed 7 May 2018.